News

Article

Risk factors for cataracts in patients with diabetes mellitus

Author(s):

Key Takeaways

  • Prolonged DM duration and poor glycemic control significantly increase cataract risk in diabetic patients.
  • CKD and DPN are identified as major comorbidities influencing cataract development in DM patients.
SHOW MORE

Researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM

(Image Credit: AdobeStock/myschka79)

(Image Credit: AdobeStock/myschka79)

A research team from Romania identified a higher risk of cataract development in patients with diabetes mellitus (DM) who have had the disease for an extended period and who have had poor glycemic control in conjunction with systemic comorbidities,1 according to first author Adriana Ivanescu. She is from the Department of Second Internal Medicine Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology, “Victor Babes” University of Medicine and Pharmacy; and the Opticlass Ophthalmology Clinic, both in Timisoara, Romania.

Because DM is a well-known cause of visual loss, the researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM. “Considering the significant impact of cataracts on the quality of life of patients with diabetes, this study aimed to investigate the most important risk factors involved in cataract development to sensitize physicians to the importance of screening and early detection of cataracts and overall health among these patients,” the investigators stated.

A total of 319 patients with a diagnosis of DM were included in the study. The investigators analyzed the patient data retrieved from the medical charts that included the DM status, metabolic control, demographic and anthropometric indices, and generally associated comorbidities.

Data analysis

The authors reported studying the risk factors of hypertension, cardiovascular disease (CVD), chronic kidney disease (CKD), diabetic polyneuropathy (DPN), dyslipidemia, and hepatic steatosis, which were present in all the study patients.

The factors identified in the patients with cataract were the high prevalence rates of hypertension (67.6%), DPN (53.3%), and dyslipidemia (46.6%).

Among them, CKD (p < 0.001) and DPN (p = 0.019) were significant predictive factors for the probability of cataract development.

An ophthalmologic evaluation showed that diabetic retinopathy (DR) reached significance in the occurrence of cataracts. In addition, patient age and DM-related factors, such as disease duration (p < 0.001) and hemoglobin A1c values (p = 0.029), significantly increased the risk of cataracts. Smoking was self-reported by 24.8% of the patients, which also was related significantly to the occurrence of cataracts (p = 0.04).

The investigators concluded, “Our findings are consistent with those in the current literature, emphasizing that poor glycemic control and extended DM duration are the most critical risk factors for cataract development in patients with diabetes. Patients with DM are known to present with multiple associated pathologies such as hypertension, CVD, CKD, DPN, hepatic steatosis, and dyslipidemia. The present study identified CKD and DPN as the most influential comorbidities on cataract occurrence and development, whereas hepatic steatosis was linked to nuclear sclerotic cataracts. While maintaining optimal glycemic control remains a cornerstone strategy for preventing ophthalmological complications in patients with DM, early detection and management of all risk factors prevents the occurrence of vision-threatening cataracts and aids healthcare providers in obtaining better patient-related outcomes.”

Reference:
  1. Ivanescu A, Popescu S, Gaita L, et al. Risk factors for cataracts in patients with diabetes mellitus. J Clin Med. 2024;13:7005; https://doi.org/10.3390/jcm13237005

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.